RACHEL ZELMAN: Open Payments
NPI 1134700727 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,819 in 79 payments from 19 companies in 2025. Trend: 2023 $1,161 · 2024 $2,729 · 2025 $1,819
Food & beverage: $1,819
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $400 |
| Lilly USA, LLC | 12 | $346 |
| Janssen Biotech, Inc. | 10 | $159 |
| PFIZER INC. | 7 | $149 |
| LEO Pharma Inc. | 4 | $103 |
| GENZYME CORPORATION | 3 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| Galderma Laboratories, L.P. | 4 | $72 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $69 |
| UCB, Inc. | 2 | $61 |
Products named: TALTZ, SKYRIZI, RINVOQ, TREMFYA, CIBINQO, DUPIXENT, EBGLYSS, ADBRY.
Industry payments across NY — which companies pay providers there.
